SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nicholas T. Lappas, Courtney M. Lappas, Forensic Toxicology, 2016,

    CrossRef

  2. 2
    Jamie P. Smith, Oliver B. Sutcliffe, Craig E. Banks, An overview of recent developments in the analytical detection of new psychoactive substances (NPSs), The Analyst, 2015, 140, 15, 4932

    CrossRef

  3. 3
    S. Assi, A. Guirguis, S. Halsey, S. Fergus, J. L. Stair, Analysis of ‘legal high’ substances and common adulterants using handheld spectroscopic techniques, Anal. Methods, 2015, 7, 2, 736

    CrossRef

  4. 4
    Laurent Karila, Bruno Megarbane, Lucie Chevillard, Nadia Benturquia, Jean-Louis Laplanche, Michel Lejoyeux, Nouveaux produits de synthèse : revue des données actuelles, La Presse Médicale, 2015, 44, 4, 383

    CrossRef

  5. 5
    Joe Kakish, Omid Tavassoly, Jeremy S. Lee, Rasagiline, a Suicide Inhibitor of Monoamine Oxidases, Binds Reversibly to α-Synuclein, ACS Chemical Neuroscience, 2015, 6, 2, 347

    CrossRef

  6. 6
    L. A. King, New phenethylamines in Europe, Drug Testing and Analysis, 2014, 6, 7-8
  7. 7
    Linda D. Simmler, Anna Rickli, York Schramm, Marius C. Hoener, Matthias E. Liechti, Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives, Biochemical Pharmacology, 2014, 88, 2, 237

    CrossRef

  8. 8
    M. Coppola, R. Mondola, 5-Iodo-2-aminoindan (5-IAI): Chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects, Toxicology Letters, 2013, 218, 1, 24

    CrossRef

  9. 9
    John M Corkery, Simon Elliott, Fabrizio Schifano, Ornella Corazza, A Hamid Ghodse, MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; ‘sparkle’; ‘mindy’) toxicity: a brief overview and update, Human Psychopharmacology: Clinical and Experimental, 2013, 28, 4
  10. 10
    Leslie A. King, Novel Psychoactive Substances, 2013,

    CrossRef

  11. 11
    Simon D. Brandt, Robin A. Braithwaite, Michael Evans-Brown, Andrew T. Kicman, Novel Psychoactive Substances, 2013,

    CrossRef

  12. 12
    Silas W. Smith, Fiona M. Garlich, Novel Psychoactive Substances, 2013,

    CrossRef

  13. 13
    Mario Thevis, Tiia Kuuranne, Hans Geyer, Wilhelm Schänzer, Annual banned-substance review: analytical approaches in human sports drug testing, Drug Testing and Analysis, 2012, 4, 1
  14. 14
    P Teale, J Scarth, S Hudson, Impact of the emergence of designer drugs upon sports doping testing, Bioanalysis, 2012, 4, 1, 71

    CrossRef

  15. You have free access to this content15
    L. A. King, A. T. Kicman, A brief history of ‘new psychoactive substances’, Drug Testing and Analysis, 2011, 3, 7-8